These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30481155)

  • 1. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.
    Schweitzer S; Kunz M; Kurlbaum M; Vey J; Kendl S; Deutschbein T; Hahner S; Fassnacht M; Dandekar T; Kroiss M
    Eur J Endocrinol; 2019 Feb; 180(2):117-125. PubMed ID: 30481155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma.
    Weng Y; Tang JY; Zhang XY; Lin DZ; Guo Y; Liang Y; Wang L; Zhou J; Yan L; Lin TX; Zhang SL
    Front Endocrinol (Lausanne); 2024; 15():1435102. PubMed ID: 39359414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma.
    Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF
    Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.
    Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M
    Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
    Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum steroid profiling by mass spectrometry in adrenocortical tumors: diagnostic implications.
    Fanelli F; Di Dalmazi G
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):160-165. PubMed ID: 30893084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
    Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
    Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
    Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders.
    Hines JM; Bancos I; Bancos C; Singh RD; Avula AV; Young WF; Grebe SK; Singh RJ
    Clin Chem; 2017 Dec; 63(12):1824-1835. PubMed ID: 28814383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma.
    Suzuki S; Minamidate T; Shiga A; Ruike Y; Ishiwata K; Naito K; Ishida A; Deguchi H; Fujimoto M; Koide H; Tatsuno I; Ikeda JI; Yamazaki Y; Sasano H; Yokote K
    BMC Endocr Disord; 2020 Nov; 20(1):173. PubMed ID: 33228607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
    Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
    Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors.
    Chortis V
    Minerva Endocrinol; 2019 Mar; 44(1):19-24. PubMed ID: 29905434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
    Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ
    Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.
    Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G
    J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum steroid profiling in the diagnosis of adrenocortical carcinoma: a prospective cohort study.
    Yu K; Athimulam S; Saini J; Kaur RJ; Xue Q; McKenzie TJ; Singh RJ; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2024 Sep; ():. PubMed ID: 39231247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
    Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status.
    Eisenhofer G; Peitzsch M; Kaden D; Langton K; Pamporaki C; Masjkur J; Tsatsaronis G; Mangelis A; Williams TA; Reincke M; Lenders JWM; Bornstein SR
    Clin Chim Acta; 2017 Jul; 470():115-124. PubMed ID: 28479316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas.
    Di Dalmazi G; Fanelli F; Mezzullo M; Casadio E; Rinaldi E; Garelli S; Giampalma E; Mosconi C; Golfieri R; Vicennati V; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3529-38. PubMed ID: 26161451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours.
    Tiu SC; Chan AO; Taylor NF; Lee CY; Loung PY; Choi CH; Shek CC
    Hong Kong Med J; 2009 Dec; 15(6):463-70. PubMed ID: 19966352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.